Ditchcarbon
  • Contact
  1. Organizations
  2. Aventis Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Aventis Inc. Sustainability Profile

Company website

Aventis Inc., a prominent player in the biotechnology and pharmaceutical industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in innovative drug development and biopharmaceutical solutions, with a strong operational presence across North America and Europe. Specialising in cutting-edge therapies for chronic diseases, Aventis Inc. is renowned for its unique approach to personalised medicine, which sets it apart from competitors. The company has achieved significant milestones, including the successful launch of several groundbreaking treatments that have transformed patient care. With a commitment to research and development, Aventis Inc. continues to enhance its market position, earning accolades for its contributions to healthcare and its dedication to improving patient outcomes.

DitchCarbon Score

How does Aventis Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Aventis Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Aventis Inc.'s reported carbon emissions

Inherited from Sanofi

Aventis Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Sanofi, from which it inherits climate commitments and initiatives. Aventis Inc. aligns its climate strategy with Sanofi's sustainability goals, which include participation in various initiatives such as the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 commitment to renewable energy. These initiatives reflect a commitment to reducing greenhouse gas emissions and transitioning to sustainable energy sources. While specific reduction targets for Aventis Inc. are not detailed, the overarching goals set by Sanofi provide a framework for emissions reduction and climate action. As a current subsidiary of Sanofi, Aventis Inc. benefits from the parent company's established climate strategies and performance metrics, which aim to enhance sustainability across its operations. In summary, while Aventis Inc. does not have specific emissions data or reduction targets available, it is committed to climate action through its association with Sanofi, leveraging inherited initiatives to drive sustainability efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20102011201220132015201920202021202220232024
Scope 1
545,114,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
677,549,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
-
0,000,000,000
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is Aventis Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aventis Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Aventis Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Aventis Inc. is in US, which has a low grid carbon intensity relative to other regions.

Aventis Inc.'s Scope 3 Categories Breakdown

Aventis Inc.'s Scope 3 emissions, which decreased by 5% last year and increased by approximately 40% since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
69%
End-of-Life Treatment of Sold Products
5%
Capital Goods
5%
Business Travel
4%
Upstream Transportation & Distribution
4%
Waste Generated in Operations
3%
Fuel and Energy Related Activities
3%
Employee Commuting
3%
Use of Sold Products
2%
Investments
<1%

Aventis Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Aventis Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Aventis Inc.'s Emissions with Industry Peers

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy